Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
Key Information
Due Date: September 7, 2026
Agency: Not Specified
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: Not Specified
Funding Type: Grant
Match Required: No
Status: Posted
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
This grant focuses on schizophrenia and related disorders that occur during mid to late life stages (participants can opt for clinical trials if desired). It's important to note that most individuals living with schizophrenia and related disorders are aged over 35 years. This includes both those newly diagnosed and those who've been living with the illness for some time. However, the underlying causes and progression of this illness are still not clearly understood. The aim of this initiative is to boost research that could help in understanding the emergence and progression of schizophrenia and related disorders in the middle to later years of life. In addition, this research hopes to identify areas to concentrate future prevention and treatment efforts.
Show More
Key Dates
Open Date: June 29, 2023
Application Due Date: September 7, 2026
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses